{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T19:19:07Z","timestamp":1787080747071,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.pharep.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T02:40:20Z","timestamp":1517798420000},"page":"694-698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The pattern of pharmacological treatment of bipolar patients discharged from psychiatric units in Poland"],"prefix":"10.1007","volume":"70","author":[{"given":"Jan","family":"Jaracz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta Tetera-","family":"Rudnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Bierejszyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaja","family":"Witczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Raczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pisarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Wo\u017aniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Czerna\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Moniakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Jaracz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2018.02.004_bib0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archpsyc.1967.01730200030005","article-title":"Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis","volume":"16","author":"Baastrup","year":"1967","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharep.2018.02.004_bib0010","first-page":"442","article-title":"Long-term thymoregulative action of depamide in manic-depressive psychoses [in French]","volume":"2","author":"Lambert","year":"1971","journal-title":"Ann Med Psychol"},{"key":"10.1016\/j.pharep.2018.02.004_bib0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00431111","article-title":"A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness","volume":"73","author":"Okuma","year":"1981","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pharep.2018.02.004_bib0020","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1017\/S0033291706009305","article-title":"What is a mood stabilizer","volume":"37","author":"Goodwin","year":"2007","journal-title":"Psychol Med"},{"key":"10.1016\/j.pharep.2018.02.004_bib0025","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1399-5618.2011.00967.x","article-title":"Atypical mood stabilizers: a new role for neuroleptics","volume":"13","author":"Malhi","year":"2011","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.pharep.2018.02.004_bib0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharep.2018.02.004_bib0035","series-title":"Lithium: 50 years of psychopharmacology, new perspectives in biomedical and clinical research","first-page":"36","article-title":"Excellent lithium responders: people whose lives have been changed by lithium prophylaxis","author":"Grof","year":"1999"},{"key":"10.1016\/j.pharep.2018.02.004_bib0040","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/JGP.0b013e318187135f","article-title":"Prescription patterns of psychotropic medications in elderly compared with younger participants who achieved a recovered status in the systematic treatment enhancement program for bipolar disorder","volume":"16","author":"Al Jurdi","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.pharep.2018.02.004_bib0045","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.psychres.2014.01.038","article-title":"Medication burden in bipolar disorder: a chart review of patients at psychiatric hospital admission","volume":"216","author":"Weinstock","year":"2014","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharep.2018.02.004_bib0050","article-title":"Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP","volume":"21","author":"Haeberle","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pharep.2018.02.004_bib0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12888-014-0282-z","article-title":"Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study","volume":"14","author":"Degli Esposti","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pharep.2018.02.004_bib0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1176\/appi.ps.201200529","article-title":"Psychotropic polypharmacy for the treatment of bipolar disorder in Taiwan","volume":"65","author":"Hung","year":"2014","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.pharep.2018.02.004_bib0065","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2147\/NDT.S100846","article-title":"Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review","volume":"12","author":"Fornaro","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.pharep.2018.02.004_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.pharep.2018.02.004_bib0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/15622970410029924","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. WFSBP task force on treatment guidelines for bipolar disorders","volume":"5","author":"Grunze","year":"2004","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.pharep.2018.02.004_bib0080","unstructured":"National Institute for Health and Care Excellence: Bipolar disorder (update): the management of bipolar disorder in adults, children and adolescents in primary and secondary care. (Clinical Guideline 185.) 2014. www.nice.org.uk\/guidance\/CG185\/InformationForPublic."},{"issue":"2","key":"10.1016\/j.pharep.2018.02.004_bib0085","first-page":"180","article-title":"The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines","volume":"20","author":"Fountoulakis","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2018.02.004_bib0090","series-title":"Standards of pharmacological treatment of some mental disorders","article-title":"Affective disorders","author":"Rybakowski","year":"2015"},{"key":"10.1016\/j.pharep.2018.02.004_bib0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/WNF.0000000000000147","article-title":"Polypharmacy in maintenance of bipolar disorder","volume":"39","author":"Peselow","year":"2016","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharep.2018.02.004_bib0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.v61n0104","article-title":"The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study","volume":"61","author":"Frye","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"10.1016\/j.pharep.2018.02.004_bib0105","doi-asserted-by":"crossref","first-page":"e28725","DOI":"10.1371\/journal.pone.0028725","article-title":"Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995\u20132009","volume":"6","author":"Hayes","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharep.2018.02.004_bib0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1176\/appi.ps.201100092","article-title":"Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998\u20132009","volume":"63","author":"Pillarella","year":"2012","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.pharep.2018.02.004_bib0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/JCP.0000000000000440","article-title":"Utilization of psychopharmacological treatment among patients with newly diagnosed bipolar disorder from 2001 to 2010","volume":"36","author":"Chang","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharep.2018.02.004_bib0120","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharep.2018.02.004_bib0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","article-title":"A efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy","volume":"59","author":"Tohen","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharep.2018.02.004_bib0130","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","article-title":"Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate\/lithium monotherapy: a placebo-controlled study","volume":"165","author":"Vieta","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharep.2018.02.004_bib0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","article-title":"Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study","volume":"6","author":"Sachs","year":"2004","journal-title":"Bipolar Dis"},{"key":"10.1016\/j.pharep.2018.02.004_bib0140","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Bowden efficacy of olanzapine and olanzapine\u2013fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharep.2018.02.004_bib0145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4088\/JCP.08m04152","article-title":"LamLit Study Group efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial","volume":"70","author":"van der Loos","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharep.2018.02.004_bib0150","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(09)61828-6","article-title":"Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial","volume":"375","author":"Geddes","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.pharep.2018.02.004_bib0155","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bdi.12459","article-title":"Antipsychotic adjunctive therapy to mood stabilizers and 1-year rehospitalization rates in bipolar disorder: a cohort study","volume":"18","author":"Hochman","year":"2016","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.pharep.2018.02.004_bib0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jad.2017.02.012","article-title":"Maintenance therapy with second-generation antipsychotics for bipolar disorder\u2014a systematic review and meta-analysis","volume":"213","author":"Lindstr\u00f6m","year":"2017","journal-title":"J Affect Disord"},{"issue":"8842","key":"10.1016\/j.pharep.2018.02.004_bib0165","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0140-6736(93)93048-6","article-title":"Interaction of lamotrigine with sodium valproate","volume":"341","author":"Panayiotopoulos","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.pharep.2018.02.004_bib0170","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/FTD.0b013e3182693d2a","article-title":"Valproic acid significantly lowers serum concentrations of olanzapine-an interaction effect comparable with smoking","volume":"34","author":"Haslemo","year":"2012","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pharep.2018.02.004_bib0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jad.2007.04.006","article-title":"Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients","volume":"105","author":"Kim","year":"2008","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharep.2018.02.004_bib0180","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1017\/S1461145713000953","article-title":"Polypharmacy and bipolar disorder: what\u2019s personality got to do with it","volume":"17","author":"Sachs","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2018.02.004_bib0185","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S2215-0366(16)30264-4","article-title":"Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials","volume":"3","author":"McGirr","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"10.1016\/j.pharep.2018.02.004_bib0190","first-page":"30","article-title":"Molecular mechanisms of bipolar disorder: progress made and future challenges","volume":"14","author":"Kim","year":"2017","journal-title":"Front Cell Neurosci"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017305340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017305340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:31Z","timestamp":1752611851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2018.02.004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1734114017305340"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2018.02.004","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pattern of pharmacological treatment of bipolar patients discharged from psychiatric units in Poland","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}